Pharmacy
It's the largest ever criminal fine levied against a pharmaceutical company for FCPA violations.
The ongoing Attorneys General investigation began in 2014, according to the complaint, and has "uncovered evidence of a broad, well-coordinated and long-running series of schemes."
Overdoses kill 90 people in the United States each day; opioid poisonings cost more than $20 billion in emergency departments, hospital care.
From sample of 1,202 adults, eight percent of respondents said they or someone in their household had imported a drug at some point.
Affordable Care Act's fate is coming into question as healthcare organizations move into the new world of value-based care and other advances.
Canadian drugmaker Valeant Pharmaceuticals International Inc. acquired the medication in February 2015 and abruptly doubled the $1,500 retail price.
Five of the six drugs with the highest cumulative price increases over the study period were marketed by Valeant Pharmaceuticals.
And as many are now doing, the company is currently awaiting what will happen to the healthcare landscape under a new presidential administration.
The increase comes on the heels of a five-year period of historically low growth, from 2009 to 2013.
A massive lobbying effort by 58 pharmaceutical companies, 24 device companies and 26 "biotech products and research" companies shaped the bill.